We are delighted to announce that Dr Naomi Stevens has joined the partnership of Boult, effective 1 May 2024.
Naomi joined Boult in 2011, having previously worked at the Memorial Sloan-Ketting Cancer Center in New York and with the University of Cambridge, conducting research into cell behaviours relevant to morphogenesis and metastasis.
Naomi’s practice spans a wide range of biotechnology disciplines. She has significant experience in the areas of disease biomarker signatures and personalised medicine, stem cell technologies and medical devices. Her promotion adds to our already exceptional biotechnology partner team. Her full profile can be found here.